Mike Leonard

PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY.

Part of PricewaterhouseCoopers International Ltd., Pricewaterhousecoopers CI LLP is a British company founded in 2004 that provides a proprietary platform for ingesting and combining streaming, time-series data from various sources to help organizations make near real-time, insights-driven decisions. The company is based in London, UK. The company also has a community of solvers who combine human ingenuity, experience, technology, and products to help organizations build trust and deliver sustained outcomes. Pricewaterhousecoopers CI invests in societal equity through its actions and its people's contributions to the communities in which they live and work. Additionally, DoubleJump, a cloud-based collaboration platform that integrates data from clinical and real-world sources to improve consumer health, is also a part of Pricewaterhousecoopers CI.

Financial Services Opportunities Investment Fund Ltd. is a closed-ended investment company. Its objective is to attain long term capital growth and income stream by investment in a diversified portfolio of investments principally in financial services businesses. The company was founded on August 30, 2016 and is headquartered in St. Peter Port, the United Kingdom.

Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers Channel Islands LLP provides a range of services to the private equity and venture capital industry in the Channel Islands. The company is based in St. Helier, UK and offers advice and services to clients in various professional services areas, including real estate. The British company also provides an overview of the private equity and venture capital industry infrastructure in the Channel Islands and lists its office locations.

Genesis Asset Managers LLP (GFM) is the Guernsey arm of Genesis Investment Management LLP (UK), a subsidiary of Affiliated Managers Group, Inc. (NYSE: AMG) in the US. The Genesis group is an emerging markets specialist which was established in 1989 and serves institutional clients.

Part of Arch Capital Group Ltd., Southern Rock Insurance Co. Ltd. is a company based in Gibraltar, Gibraltar. Michael Lee has been the CEO of the Gibraltar company since 2011.

Channel Islands Property Fund Ltd. is a closed-ended investment company, which engages in the acquisition and holding of commercial property interests. The company's investment objective is to provide a total return from a combination of capital growth and an appropriate dividend policy through the acquisition and active management of commercial property predominantly in the Channel Islands. Its activity also include investment in commercial properties in Guernsey, Jersey, and the Isle of Man. The company was founded on August 25, 2010 and is headquartered in St. Peter Port, the United Kingdom.

The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members.

Apax Guernsey Managers Ltd is an independent private equity firm founded in 2010. The firm is headquartered in Guernsey, UK.

The Multiple Sclerosis Society is an organization that aims to find treatments for everyone affected by multiple sclerosis. The non-profit company is based in London, UK. The British company offers award-winning publications, factsheets, and booklets through their online shop. The society conducts surveys to shape the future direction of MS research, with the latest survey held in 2022 with over 6,500 participants. The company's current focus is on the STARMS trial, which compares HSCT with other highly effective treatments for relapsing MS. The treatment involves using chemotherapy to remove harmful immune cells and regrow the immune system using the patient's own stem cells. Nick Moberly has been the CEO of the company since 2019.